1. Home
  2. |Insights
  3. |Pay to Play: CFIUS Implementing Fees for Submissions of Voluntary Notices

Pay to Play: CFIUS Implementing Fees for Submissions of Voluntary Notices

Client Alert | 1 min read | 03.06.20

On March 4, 2020, the Department of Treasury released a proposed rule to implement section 1723 of the Foreign Investment Risk Review Modernization Act of 2018 (FIRRMA) and require filing fees on voluntary notices to the Committee on Foreign Investment in the United States (CFIUS) for transactions that exceed $500,000. No fee will be required for the abbreviated declarations, whether voluntary or mandatory. The proposal adopts a sliding fee structure from $750 to $300,000 based upon transaction value:

< $500,000

$0

> $500,000 but < $5 million

$750

> $5 million but < $50 million

$7,500

> $50 million but < $250 million

$75,000

> $250 million but < $750 million

$150,000

> $ 750 million

$300,000


Some issues for comment over the next thirty days include (1) impact of the fees on the calculus for assessing whether to submit a voluntary disclosure; (2) appropriateness of the proposed tiers; and (3) valuation of certain transactions where it cannot be readily determined from the total transaction price.

Contacts

Insights

Client Alert | 6 min read | 04.29.26

CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)

On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies....

View All Insights